FDA Approves Third of New Migraine Drugs

FDA Approves Third of New Migraine Drugs  WebMD FDA Approves Another Migraine Drug That Might Not Cost A Lot...For Now  Newsy FDA Greenlights Galcanezumab (Emgality) for Migraine Prevention  Medscape Lilly's Emgality™ (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults ...  Investor Relations - Eli Lilly Lilly's Emgality™ (galcanezumab-gnlm) Receives US FDA Approval for the Preventive Treatment of Migraine in Adults  PR NewswireFull coverage

(CLICK HERE TO READ AND SEE MORE)